RSSCategory: Recent News

Patients Who Choose No Intervention for Small Thyroid Cancers Report Lack of Support

| April 27, 2017 | 0 Comments

Patients Who Choose No Intervention for Small Thyroid Cancers Report Lack of Support Patients who choose not to pursue immediate biopsy or treatment for small, asymptomatic thyroid cancers, or suspected cancers, can experience a lack of support from doctors and loved ones, a new study shows.See Original Article

Continue Reading

Program Spotlight: Training Navigation

| April 26, 2017 | 0 Comments

Program Spotlight: Training Navigation Dr. Hana Odeh talks about CRCHD’s new training navigation initiative and her role as training navigator. See Original Article

Continue Reading

PARP Inhibitors May Be Effective in Brain, Other Cancers with IDH Mutations

| April 24, 2017 | 0 Comments

PARP Inhibitors May Be Effective in Brain, Other Cancers with IDH Mutations Studies presented at the 2017 AACR annual meeting suggest that therapies which take advantage of the mutations in the IDH gene may be more effective than drugs that block it.See Original Article

Continue Reading

Making Greater Progress Against Cancer—Not Just a Hope but a Reality

| April 21, 2017 | 0 Comments

Making Greater Progress Against Cancer—Not Just a Hope but a Reality Acting NCI Director Dr. Doug Lowy discusses what he calls encouraging news in the most recent Annual Report to the Nation and how NCI is helping to achieve further progress against cancer.See Original Article

Continue Reading

New Treatment Target Identified for Key Prostate Cancer Driver

| April 19, 2017 | 0 Comments

New Treatment Target Identified for Key Prostate Cancer Driver Researchers have identified a potential alternative approach to blocking a key molecular driver of an advanced form of prostate cancer, called androgen-independent or castration-resistant prostate cancer.See Original Article The Moonshot Blue Ribbon Panel: Moving Toward a Final Report An update on the activities of the National […]

Continue Reading

Mentor Spotlight: Elva M. Arredondo, PhD

| April 18, 2017 | 0 Comments

Mentor Spotlight: Elva M. Arredondo, PhD Lilian G. Perez, MPH, a fifth-year PhD Candidate, shares how being mentored by Elva M. Arredondo, PhD, a Professor in the Division of Health Promotion and Behavioral Science at San Diego State University, has positively influenced her career development.See Original Article

Continue Reading

FDA Approves Pembrolizumab for Hodgkin Lymphoma

| April 17, 2017 | 0 Comments

FDA Approves Pembrolizumab for Hodgkin Lymphoma The FDA approved pembrolizumab for the treatment of some adult and pediatric patients with classical Hodgkin lymphoma.See Original Article

Continue Reading

Studies Identify Potential Treatment Strategies for Pediatric DIPG Brain Tumors

| April 13, 2017 | 0 Comments

Studies Identify Potential Treatment Strategies for Pediatric DIPG Brain Tumors Two studies have identified proteins that drive growth of diffuse intrinsic pontine glioma (DIPG) tumor cells. Blocking these targets with investigational drugs slowed tumor growth in animal models.See Original Article

Continue Reading

Multiple Myeloma Awareness and African American Disparities

| April 13, 2017 | 0 Comments

Multiple Myeloma Awareness and African American Disparities As part of National Minority Cancer Awareness Week, we discuss multiple myeloma, a cancer that disproportionately affect minorities, and awareness of this cancer in African American communities.See Original Article

Continue Reading

Celebrating National Minority Health Month 2017

| April 12, 2017 | 0 Comments

Celebrating National Minority Health Month 2017 In recognition of National Minority Health Month, learn more about NCI programs, funding mechanisms, tools, and events that focus on cancer health disparities research, cancer types and disparities, and building a diverse biomedical workforce.See Original Article

Continue Reading